Epidemiology and Impact of Social Hardships in Children With Multiple Sclerosis in the United States
Authors:
- Elizabeth WilsonEWElizabeth Wilson
- Huong D. MeeksHMHuong D. Meeks
- Bradley J. BarneyBBBradley J. Barney
- Michael WaltzMWMichael Waltz
- Katia CanenguezKCKatia Canenguez
- T. Charles CasperTCT. Charles Casper
- John W. RoseJRJohn W. Rose
- Moses RodriguezMRMoses Rodriguez
- Jan-Mendelt TillemaJTJan-Mendelt Tillema
- Tanuja ChitnisTCTanuja Chitnis
- Mark P. GormanMGMark P. Gorman
- Mary RenselMary Rensel
- 10 December 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 103 (11) , e209991
Abstract
Social determinants of health (SDOH) affect patient health outcomes, but the impact on patients with pediatric-onset multiple sclerosis (POMS) has not been well studied. Study objectives were to (1) describe the frequency of adverse SDOH, (2) evaluate social hardships as a potential barrier to the initiation of disease-modifying therapy (DMT), and (3) explore the association between adverse SDOH and disease outcomes in POMS, as well as study attrition. This was a retrospective multicenter observational study conducted through the United States Network of Pediatric MS Centers database. Participants were patients diagnosed with POMS (excluding primary progressive MS). The primary outcome was time to initiation of DMT. Secondary outcomes included most recent Expanded Disability Status Scale (EDSS) score, steroid treatment for the first event, time to second event, and study attrition. Demographic variables and clinical outcomes were compared between patients with and without hardships (maternal education of high school or less, public insurance/no insurance, or single/no-income household). Multivariable regression models were used to assess the impact of social hardship on study outcomes. There were 996 total participants (69% female, mean age at symptom onset and EDSS score [±SD] were 14.2 ± 3 and 1.2 ± 1.1, respectively). Of 768 patients with complete demographic information, 66% reported a hardship. Hardship was associated with younger age at symptom onset and diagnosis. While there was no difference in time to DMT initiation, patients with hardship were more likely to receive steroids for the first event (odds ratio [OR] 1.66, 95% CI 1.21-2.26, p = 0.002). Lack of private insurance was associated with increased risk of study attrition (OR 1.85, 95% CI 1.14-3.00, p = 0.012) and higher EDSS score (β = 0.15, 95% CI 0.01, 0.28). Living in a no-income household (vs dual-income) was associated with a shorter time to second event (hazard ratio 1.33, 95% CI 1.02-1.74, p = 0.034). The experience of hardships is common and associated with younger age at symptom onset and diagnosis, as well as shorter time to second event. Lack of private insurance is associated with study attrition and a higher EDSS score despite no difference in time to initiating DMT. There may be differences in early disease pathophysiology related to social hardship, and future studies are needed to better understand this complex relationship.Keywords
This publication has 47 references indexed in Scilit:
- Premorbid Sociodemographic Status and Multiple Sclerosis Outcomes in a Universal Health Care ContextJAMA Network Open, 2023
- A comparison of different methods to adjust survival curves for confoundersStatistics in Medicine, 2023
- Risk of Persistent Disability in Patients With Pediatric-Onset Multiple SclerosisJAMA Neurology, 2021
- Early Predictors of 9‐Year Disability in Pediatric Multiple SclerosisAnnals of Neurology, 2021
- Do upsetting life events explain the relationship between low socioeconomic status and systemic inflammation in childhood? Results from a longitudinal studyBrain, Behavior, and Immunity, 2020
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple SclerosisJAMA, 2019
- ggplot22016
- Elevated relapse rates in pediatric compared to adult MS persist for at least 6 yearsMultiple Sclerosis and Related Disorders, 2014
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Modeling Survival Data: Extending the Cox Model2000